bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 9% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $39.14 to $42.70 in the past one-month time frame.
In the last 30 days, the company witnessed five downward estimate revisions and its Zacks Consensus Estimate of a loss widened over the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
bluebird bio currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some other players in the healthcare industry include Affymetrix Inc. (AFFX), Biogen Idec Inc. (BIIB) and Illumina Inc. (ILMN), all carrying a Zacks Rank #1 (Strong Buy)
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment